Other studies have reported that changes in plasma EV EpCAM levels correlate with ovarian cancer (Im et al., 2014; Zhao et al., 2016) and breast cancer (Rupp et al., 2011). This evidence concerns the gene EPCAM and ovarian carcinoma.